(Q44858562)

6 December 2017

title

CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era (English)

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

24 July 2024

0 references

7

Geneviève Chêne

1 reference

6 December 2017

2

Andrew Phillips

1 reference

6 December 2017

4

Nikos Pantazis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20885283

24 July 2024

author name string

Sara Lodi

1

1 reference

6 December 2017

Giota Touloumi

3

1 reference

6 December 2017

Abdel Babiker

6

1 reference

6 December 2017

Philippe Vanhems

8

1 reference

6 December 2017

Kholoud Porter

9

1 reference

6 December 2017

CASCADE Collaboration

10

1 reference

6 December 2017

Andrew Phillips

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20885283

24 July 2024

Heiner C. Bucher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20885283

24 July 2024

language of work or name

English

0 references

publication date

1 November 2010

1 reference

6 December 2017

13 November 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20885283

24 July 2024

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

17

1 reference

6 December 2017

page(s)

2697-2704

1 reference

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

6 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion

24 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Repeat HIV testing: high-risk behaviour or risk reduction strategy?

24 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Incidence of HIV infection among gay men in a London HIV testing clinic, 1997–1998

24 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss

24 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections

24 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation

24 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

24 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship

24 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

24 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

24 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

The use of fractional polynomials to model continuous risk variables in epidemiology

24 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Simple fitting of subject-specific curves for longitudinal data.

24 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort.

24 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

24 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Estimation and comparison of rates of change in longitudinal studies with informative drop-outs

24 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

24 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study

24 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

24 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania

24 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection

24 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan

24 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study

24 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Late presenters in an HIV surveillance system in Italy during the period 1992-2006.

24 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Late diagnosis in the HAART era: proposed common definitions and associations with mortality

24 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002.

24 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Biological and virologic characteristics of primary HIV infection

24 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

Human immunodeficiency virus type 1 subtypes differ in disease progression

24 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/QAD.0B013E32833EF6C4

24 July 2024

Identifiers

1 reference

6 December 2017

1 reference